ANIX vs COP · rev $210.0K vs P/E 19, rev $58.94B
Anixa Biosciences Inc (ANIX) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
Anixa Biosciences Inc (ANIX) is a biotechnology company listed on US.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported ANIX revenue for 2024-10-31 was $210.0K. Net income was -$12.7M. Revenue was up 0.0% from 2023-10-31 to 2024-10-31. ANIX currently screens at market cap $101.1M.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
ANIX currently screens at market cap $101.1M. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the ANIX and COP stock pages for the full models.
Not investment advice.